Better QOL with etanercept in children with JIA
- … show all 0 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Health-related QOL improves significantly after the start of treatment with etanercept in children with juvenile idiopathic arthritis (JIA), according to the results of a study conducted in Germany.
The study, conducted as part of a national observational cohort study, involved 61 randomly selected children (mean age 11 years) with polyarticular JIA who started etanercept treatment between January 2008 and May 2010.* QOL was assessed using the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales at baseline and at various time points over the 12-month treatment period.
The study showed that QOL in all domains increased significantly in the first 6 months after the start of treatment with etanercept. During the following 6 months of treatment, however, there were no further increases in PedsQL total scores. Nevertheless, QOL remained at a high level, note the researchers, with "some minor fluctuations". Furthermore, the number of patients with inactive disease increased du ...
- Klotsche J, et al. Improvement in Health-related Quality of Life for children with juvenile idiopathic arthritis after start of treatment with etanercept. Arthritis care and research : 27 Aug 2013. Available from: URL: http://dx.doi.org/10.1002/acr.22112
- Better QOL with etanercept in children with JIA
PharmacoEconomics & Outcomes News
Volume 688, Issue 1 , p 10
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors